Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S86-90. doi: 10.1016/j.amepre.2012.09.035.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Buprenorphine
  • Diffusion of Innovation*
  • HIV Infections / complications
  • HIV Infections / prevention & control*
  • Humans
  • Physician's Role
  • Primary Prevention
  • Substance-Related Disorders / complications*

Substances

  • Anti-HIV Agents
  • Buprenorphine